ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
4,273
Screening encounters
5,107
Diagnostic referrals
968
Outstanding pathways
323

Screening pathway

  1. Screening5,107Encounters
  2. Positive finding1,762Documented findings
  3. Referral968Diagnostic referrals
  4. Follow-up1,168Diagnostic visits
  5. Outcome645Resolved pathways

Stage totals use different units. Pending pathways: 323. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 0109 · EXP-0109Synthetic · Site D

Full participant history through 2027-02-10, across modalities and pathways.

  1. · Screening · VIA · Initial · Programme entry
  2. · Screening result · VIA · VIA positive · Adequate
  3. · Repeat plan · HPV DNA · Prior VIA positive · Scheduled for 2026-02-03
  4. · Diagnostic referral · EXP-0109-T-R
  5. · Contact attempt · Unsuccessful
  6. · Diagnostic booking · Initial booking
  7. · Contact attempt · Unsuccessful
  8. · Barrier documented · Transport difficulty
  9. · Contact attempt · Reached
  10. · Diagnostic visit · Missed
  11. · Diagnostic booking · Rebooking
  12. · Diagnostic visit · Attended
  13. · Diagnosis · Colposcopy · Biopsy collected
  14. · Diagnosis · Histopathology · High-grade lesion
  15. · Follow-up disposition · Resolved · EXP-0109-T-R
  16. · Treatment · Synthetic precancer treatment
  17. · Surveillance plan · HPV DNA · After treatment · Scheduled for 2026-11-13
  18. · Screening · HPV DNA · Repeat · Prior VIA positive
  19. · Screening result · HPV DNA · HPV not detected · Adequate

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Unresolved

Screened participants

4273 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-0516 · Expanded synthetic participant 0516Site A — Urban Referral Hub
EXP-0517 · Expanded synthetic participant 0517Site B — Peri-Urban Access Programme
EXP-0518 · Expanded synthetic participant 0518Site A — Urban Referral Hub
EXP-0520 · Expanded synthetic participant 0520Site E — Resource-Constrained Navigation Programme
EXP-0521 · Expanded synthetic participant 0521Site D — Community Engagement Programme
EXP-0522 · Expanded synthetic participant 0522Site A — Urban Referral Hub
EXP-0523 · Expanded synthetic participant 0523Site A — Urban Referral Hub
EXP-0524 · Expanded synthetic participant 0524Site A — Urban Referral Hub
EXP-0526 · Expanded synthetic participant 0526Site B — Peri-Urban Access Programme
EXP-0527 · Expanded synthetic participant 0527Site A — Urban Referral Hub
EXP-0528 · Expanded synthetic participant 0528Site D — Community Engagement Programme
EXP-0529 · Expanded synthetic participant 0529Site C — Rural Outreach Programme
EXP-0531 · Expanded synthetic participant 0531Site D — Community Engagement Programme
EXP-0532 · Expanded synthetic participant 0532Site D — Community Engagement Programme
EXP-0533 · Expanded synthetic participant 0533Site C — Rural Outreach Programme
EXP-0534 · Expanded synthetic participant 0534Site B — Peri-Urban Access Programme
EXP-0536 · Expanded synthetic participant 0536Site D — Community Engagement Programme
EXP-0537 · Expanded synthetic participant 0537Site B — Peri-Urban Access Programme
EXP-0538 · Expanded synthetic participant 0538Site A — Urban Referral Hub
EXP-0539 · Expanded synthetic participant 0539Site B — Peri-Urban Access Programme
EXP-0540 · Expanded synthetic participant 0540Site E — Resource-Constrained Navigation Programme
EXP-0541 · Expanded synthetic participant 0541Site B — Peri-Urban Access Programme
EXP-0543 · Expanded synthetic participant 0543Site A — Urban Referral Hub
EXP-0545 · Expanded synthetic participant 0545Site E — Resource-Constrained Navigation Programme
EXP-0546 · Expanded synthetic participant 0546Site D — Community Engagement Programme

Programme insights

Encounters by modality

VIA
1930
HPV DNA
2465
Cytology
712

Navigation activity

Barrier documented
875
Contact attempt
1410
Navigation intervention
381
Diagnostic booking
1206
Diagnostic visit
1168

Documented barriers

Contact difficulty
281
Transport difficulty
287
Appointment coordination
307

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.